Literature DB >> 2054978

Asymmetrical cerebral atrophy in Alzheimer's disease.

O Bugiani1, J Constantinidis, B Ghetti, C Bouras, F Tagliavini.   

Abstract

In most Alzheimer patients brain atrophy seems to be symmetrical. Recent neuropsychological and brain imaging investigations suggest, however, that in some patients one hemisphere is more severely affected from the onset of symptoms. We have observed four Alzheimer patients with grossly asymmetrical cerebral atrophy at autopsy, in whom the topography of the most severe atrophy was consistent with the earliest clinical signs of focal brain damage. In the three patients who at onset had relevant language disorders, atrophy of the brain was more severe in the association areas surrounding the left sylvian fissure. In the fourth patient, who first complained of visuospatial troubles, the right, nondominant hemisphere was more affected. These clinical and pathological findings suggest that association areas of one hemisphere were involved quite early in the evolution of the disease, conceivably at the same time as the hippocampus and related limbic structures. In these patients, a morphometric analysis of cortical changes in homologous areas of the cortex (area 22) was carried out in order to investigate the effect of the evolution of the disease upon cortical changes. This analysis showed that the numerical densities of nerve cells and tangle-bearing neurons were lower on the more atrophied side and suggested that the severity of cortical atrophy might have affected the size, but not the density, of senile plaques.

Entities:  

Mesh:

Year:  1991        PMID: 2054978

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

Review 1.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

2.  Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Authors:  Y Likitjaroen; T Meindl; U Friese; M Wagner; K Buerger; H Hampel; S J Teipel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-08-05       Impact factor: 5.270

3.  The Geneva brain collection.

Authors:  Enikö Kövari; Patrick R Hof; Constantin Bouras
Journal:  Ann N Y Acad Sci       Date:  2011-05       Impact factor: 5.691

4.  Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases.

Authors:  P Giannakopoulos; P R Hof; C Bouras
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins.

Authors:  P Vermersch; B Frigard; A Delacourte
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 6.  Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives.

Authors:  Mina Park; Won-Jin Moon
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

7.  Identifying a subtype of Alzheimer's disease characterised by predominant right focal cortical atrophy.

Authors:  Ko Woon Kim; Seongbeom Park; Hyunjin Jo; Soo Hyun Cho; Seung Joo Kim; Yeshin Kim; Hyemin Jang; Duk L Na; Sang Won Seo; Hee Jin Kim
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.